Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms

NCT02056574 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Subarachnoid Hemorrhage
Ruptured Intracranial Aneurysm

Interventions

DRUG: NA-1
DRUG: Placebo

Sponsor

NoNO Inc.